Peritoneal cancer characterized by localized dissemination can be hard to treat due to a poor understanding of cellular properties driving metastasis. Using natural fibrillar environments, we present high throughput and high content quantitative strategy to measure biophysical properties of cells in ovarian cancer models on the timescale of hours.
17 July 2020 in Mini-Reviews in Medicinal Chemistry
Protein tyrosine phosphatase 2 (SHP-2) has long been proposed as a cancer drug target. Several small-molecule compounds with different mechanisms of SHP-2 inhibition have been reported, but none are commercially available. Pool selectivity over protein tyrosine phosphatase 1 (SHP-1) and a lack of cellular activity have hindered the development of selective SHP-2 inhibitors. In this review, we describe the binding modes of existing inhibitors and SHP-2 binding sites, summarize the characteristics of the sites involved in selectivity, and identify the suitable groups for interaction with the binding sites.